Version 1
: Received: 17 April 2020 / Approved: 19 April 2020 / Online: 19 April 2020 (05:42:22 CEST)
How to cite:
Honardoost, M.; Aghili, R.; Khamseh, M. E. Coronavirus 2019 Infection in People with Associated Co-Morbidities: Case Fatality and ACE2 Inhibitors Treatment Concerns. Preprints2020, 2020040331. https://doi.org/10.20944/preprints202004.0331.v1
Honardoost, M.; Aghili, R.; Khamseh, M. E. Coronavirus 2019 Infection in People with Associated Co-Morbidities: Case Fatality and ACE2 Inhibitors Treatment Concerns. Preprints 2020, 2020040331. https://doi.org/10.20944/preprints202004.0331.v1
Honardoost, M.; Aghili, R.; Khamseh, M. E. Coronavirus 2019 Infection in People with Associated Co-Morbidities: Case Fatality and ACE2 Inhibitors Treatment Concerns. Preprints2020, 2020040331. https://doi.org/10.20944/preprints202004.0331.v1
APA Style
Honardoost, M., Aghili, R., & Khamseh, M. E. (2020). Coronavirus 2019 Infection in People with Associated Co-Morbidities: Case Fatality and ACE2 Inhibitors Treatment Concerns. Preprints. https://doi.org/10.20944/preprints202004.0331.v1
Chicago/Turabian Style
Honardoost, M., Rokhsareh Aghili and Mohammad E. Khamseh. 2020 "Coronavirus 2019 Infection in People with Associated Co-Morbidities: Case Fatality and ACE2 Inhibitors Treatment Concerns" Preprints. https://doi.org/10.20944/preprints202004.0331.v1
Abstract
The Corona Virus Disease 2019 (COVID-19) outbreak is becoming pandemic with the highest mortality in people with associated comorbidities. These RNA viruses containing four structural proteins usually use spike protein to enter the host cell. It has been demonstrated that Angiotensin Converting Enzyme 2 (ACE2) ,as a part of renin-angiotensin-aldosterone system (RAAS), acts as a host receptor for the virus which is the main target of therapeutic approaches. However, medications acting on RAAS can lead to serious complications especially in people with diabetes and hypertension. To avoid this, other potential treatment modalities should be used in COVID-19 patients with associated comorbidities.
Keywords
COVID-19; associated comorbidities; treatment; ACE2 inhibitors; Type 2 diabetes
Subject
Medicine and Pharmacology, Epidemiology and Infectious Diseases
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.